• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Silence Therapeutics Plc - American Depository Share (NQ:SLN)

    10.95 +0.46 (+4.39%)
    Streaming Delayed Price Updated: 12:18 PM EDT, Aug 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 240,882
    Open 10.53
    Bid (Size) 10.95 (200)
    Ask (Size) 11.00 (200)
    Prev. Close 10.49
    Today's Range 10.32 - 11.25
    52wk Range 4.190 - 12.19
    Shares Outstanding 107,808,471
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera
    From Silence Therapeutics plc
    Via Business Wire
    News headline image
    Silence Therapeutics to Participate in Jefferies Global Healthcare Conference
    From Silence Therapeutics plc
    Via Business Wire

    Performance

    YTD
    +78.0%
    +78.0%
    1 Month
    +3.5%
    +3.5%
    3 Month
    +50.2%
    +50.2%
    6 Month
    +123.5%
    +123.5%
    1 Year
    +84.0%
    +84.0%

    More News

    Read More
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference
    From Silence Therapeutics plc
    Via Business Wire
    News headline image
    Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results
    From Silence Therapeutics plc
    Via Business Wire
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Wednesday's session. ↗
    Via Chartmill
    Top movers in Thursday's session ↗
    Via Chartmill
    Monday's session: gap up and gap down stocks ↗
    Via Chartmill
    Here are the top movers in Monday's session. ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Friday's session. ↗
    Via Chartmill
    Which stocks are gapping on Friday? ↗
    Via Chartmill
    Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session. ↗
    Via Chartmill
    Here are the top movers in Thursday's session. ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Thursday. ↗
    Via Chartmill
    Top movers in Friday's session ↗
    Via Chartmill
    Which stocks are moving on Thursday? ↗
    Via Chartmill
    Get insights into the top gainers and losers of Thursday's pre-market session. ↗
    Via Chartmill
    News headline image
    Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results
    From Silence Therapeutics plc
    Via Business Wire
    News headline image
    Silence Therapeutics Announces Leadership Changes
    From Silence Therapeutics plc
    Via Business Wire
    News headline image
    Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake ↗
    Via The Motley Fool
    News headline image
    Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference
    From Silence Therapeutics plc
    Via Business Wire
    News headline image
    Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
    From Silence Therapeutics plc
    Via Business Wire
    News headline image
    Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV)
    From Silence Therapeutics plc
    Via Business Wire

    Frequently Asked Questions

    Is Silence Therapeutics Plc - American Depository Share publicly traded?
    Yes, Silence Therapeutics Plc - American Depository Share is publicly traded.
    What exchange does Silence Therapeutics Plc - American Depository Share trade on?
    Silence Therapeutics Plc - American Depository Share trades on the Nasdaq Stock Market
    What is the ticker symbol for Silence Therapeutics Plc - American Depository Share?
    The ticker symbol for Silence Therapeutics Plc - American Depository Share is SLN on the Nasdaq Stock Market
    What is the current price of Silence Therapeutics Plc - American Depository Share?
    The current price of Silence Therapeutics Plc - American Depository Share is 10.95
    When was Silence Therapeutics Plc - American Depository Share last traded?
    The last trade of Silence Therapeutics Plc - American Depository Share was at 08/03/26 12:18 PM ET
    What is the market capitalization of Silence Therapeutics Plc - American Depository Share?
    The market capitalization of Silence Therapeutics Plc - American Depository Share is 1.18B
    How many shares of Silence Therapeutics Plc - American Depository Share are outstanding?
    Silence Therapeutics Plc - American Depository Share has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.